We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

15 hedge funds and large institutions have $812K invested in NeuroMetrix, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

6% less funds holding

Funds holding: 1615 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

49% less capital invested

Capital invested by funds: $1.6M → $812K (-$784K)

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
6
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

NURO Hedge Fund Activity: Q4 2022 in Review

15 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q4 2022, worth a combined $812K — down 49% from $1.6M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NURO and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 6 added.

The largest buyer was Millennium Management, adding an estimated $18.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $97K sold.

  • 15 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q4 2022, down from 16 in Q3 2022.
  • Funds reported $812K of NeuroMetrix, Inc. Common Stock stock for Q4 2022, down 49% quarter-over-quarter.
  • 2 funds opened new NeuroMetrix, Inc. Common Stock positions in Q4 2022 and 3 closed out, a net change of -1 holder.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q4 2022 was Millennium Management, an estimated $18.5K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q4 2022 was Citadel Advisors, an estimated $97K sold.

Based on aggregated 13F filings for Q4 2022.